Home All Victims glenmarkpharma.com

glenmarkpharma.com

incransom
Country
India
Business Category
Healthcare / Pharma
Employees
+1000
Discovered
2026-03-25
Published
March 25, 2026
Victim ID
4Vgz5ncnboY8

Description

Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide. Rajeev Sharma Senior Vice President and Chief Financial Officer - North America Laura Lester Senior Vice President & General Counsel - North America Jim Brown Senior Vice President Firas B Abulaban Senior Vice President and Corporate Quality Head of North America Bradley Nowels Vice President Institutional Sales – North America Vishal Arora Vice President of Business Development and Licensing Michael Pope Executive Director and Site Head – Monroe, NC Adam Subervi Chief Compliance Officer Fabio Moreno Executive Director and Head of the OTC Business Kathleen (Kathy) McKenna Senior Director – Human Resources INVESTORS Company Secretary & Compliance Officer ComplianceOfficer@glenmarkpharma.com Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: einward.ris@kfintech.com Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099 KFINTECH Corporate Website: www.kfintech.com RTA Website: https://ris.kfintech.com Investor Support Centre (DIY Link) https://ris.kfintech.com/clientservices/isc BUSINESS DEVELOPMENT For queries related to collaboration and partnership, please email to : businessdevelopment.web@glenmarkpharma.com INVESTORS Company Secretary & Compliance Officer ComplianceOfficer@glenmarkpharma.com Tel No.: +91 22 4018 9999 ------------------------------------------- GRIEVANCE OFFICER grievance.officer@glenmarkpharma.com Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 ------------------------------------------- REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: einward.ris@kfintech.com Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099

Visit Website Original Post View Group: incransom
Legal Disclaimer: Breach.house does not engage in the acquisition, exfiltration, downloading, possession, hosting, access, consultation, redistribution, or disclosure of unlawfully obtained data. This platform indexes only publicly visible information posted by ransomware, breaches, leads and infostealers operators and open web sources without accessing or obtaining the underlying stolen content. The service is provided to support public awareness, legitimate research, and cyber-resilience. No stolen personal or confidential data is collected or distributed via this site.